4.7 Article

Recommendations for measurement of tumour vascularity with positron emission tomography in early phase clinical trials

Journal

EUROPEAN RADIOLOGY
Volume 22, Issue 7, Pages 1465-1478

Publisher

SPRINGER
DOI: 10.1007/s00330-011-2311-3

Keywords

Tumour vascularity; Positron emission tomography; Angiogenesis; [O-15]-water; Integrin receptor ligand

Funding

  1. Cancer Research UK
  2. National Institute for Health Research in England
  3. Department of Health for Scotland
  4. Department of Health for Wales
  5. Department of Health for Northern Ireland
  6. Cancer Research UK [10337] Funding Source: researchfish
  7. National Institute for Health Research [NIHR/CS/009/009] Funding Source: researchfish
  8. National Institutes of Health Research (NIHR) [NIHR/CS/009/009] Funding Source: National Institutes of Health Research (NIHR)

Ask authors/readers for more resources

The evaluation of drug pharmacodynamics and early tumour response are integral to current clinical trials of novel cancer therapeutics to explain or predict long term clinical benefit or to confirm dose selection. Tumour vascularity assessment by positron emission tomography could be viewed as a generic pharmacodynamic endpoint or tool for monitoring response to treatment. This review discusses methods for semi-quantitative and quantitative assessment of tumour vascularity. The radioligands and radiotracers range from direct physiological functional tracers like [O-15]-water to macromolecular probes targeting integrin receptors expressed on neovasculature. Finally we make recommendations on ways to incorporate such measurements of tumour vascularity into early clinical trials of novel therapeutics. Key Points aEuro cent [ (15) O]-water is the gold standard for blood flow/tissue perfusion with PET aEuro cent In some instances dynamic [ (18) F]-FDG uptake may be used to estimate perfusion aEuro cent Radiopharmaceuticals that target integrins are now being evaluated for measuring tumour vascularity.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Critical Care Medicine

Diagnostic Accuracy of a Convolutional Neural Network Assessment of Solitary Pulmonary Nodules Compared With PET With CT Imaging and Dynamic Contrast-Enhanced CT Imaging Using Unenhanced and Contrast-Enhanced CT Imaging

Jonathan R. Weir-McCall, Elise Debruyn, Scott Harris, Nagmi R. Qureshi, Robert C. Rintoul, Fergus Gleeson, Fiona J. Gilbert

Summary: A lung cancer prediction convolutional neural network (LCP-CNN) demonstrates diagnostic performance comparable to PET with CT imaging in the diagnosis of solitary pulmonary nodules. The LCP-CNN outperforms dynamic contrast-enhanced (DCE) CT imaging in accuracy, while being equal to PET with CT imaging.

CHEST (2023)

Biographical-Item Radiology, Nuclear Medicine & Medical Imaging

Francis William Smith, MD, FRCR, FRCS, FRCP, FFSEM (UK) (1943-2022) Obituary

Gordon D. Waiter, Fiona J. Gilbert, Alison Murray, Beverly MacLennan

JOURNAL OF MAGNETIC RESONANCE IMAGING (2023)

Article Cardiac & Cardiovascular Systems

Somatostatin Receptor PET/MR Imaging of Inflammation in Patients With Large Vessel Vasculitis and Atherosclerosis

Andrej Corovic, Christopher Wall, Meritxell Nus, Deepa Gopalan, Yuan Huang, Maria Imaz, Michal Zulcinski, Marta Peverelli, Anna Uryga, Jordi Lambert, Dario Bressan, Robert T. Maughan, Charis Pericleous, Suraiya Dubash, Natasha Jordan, David R. Jayne, Stephen P. Hoole, Patrick A. Calvert, Andrew F. Dean, Doris Rassl, Tara Barwick, Mark Iles, Mattia Frontini, Greg Hannon, Roido Manavaki, Tim D. Fryer, Luigi Aloj, Martin J. Graves, Fiona J. Gilbert, Marc R. Dweck, David E. Newby, Zahi A. Fayad, Gary Reynolds, Ann W. Morgan, Eric O. Aboagye, Anthony P. Davenport, Helle F. Jorgensen, Ziad Mallat, Martin R. Bennett, James E. Peters, James H. F. Rudd, Justin C. Mason, Jason M. Tarkin

Summary: This study investigates the feasibility of using somatostatin receptor 2 (SST2) as a molecular imaging target for inflammation in large vessel vasculitis (LVV), and provides evidence for its potential in the diagnosis and therapeutic monitoring of LVV.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Input function and modeling for determining bone metabolic flux using [18F] sodium fluoride PET imaging: A step-by-step guide

Tanuj Puri, Michelle L. Frost, Amelia E. B. Moore, Gary J. R. Cook, Glen M. Blake

Summary: This article introduces the method of measuring bone metabolic flux (K-i) using [F-18] sodium fluoride ([F-18]NaF) positron emission tomography (PET) scans, and proposes a simplified method that estimates K-i values from static scans and venous blood samples. By reviewing different methods of measuring arterial input functions (AIF), a non-invasive method for studying bone metabolism without arterial blood sampling is provided, which shortens scan times, simplifies procedures, and reduces costs.

MEDICAL PHYSICS (2023)

Review Biotechnology & Applied Microbiology

Amplified therapeutic targets in high-grade serous ovarian carcinoma - a review of the literature with quantitative appraisal

Thomas Talbot, Haonan Lu, Eric O. Aboagye

Summary: High-grade serous ovarian carcinoma is characterized by universal TP53 mutations and widespread copy number alterations, including deletion of tumor suppressors and amplification of driver oncogenes. Amplified driver genes have been proposed as therapeutic targets. However, lack of validation and variable experimental procedures hinder clinical translation. This review collates candidate amplified therapeutic targets in high-grade serous ovarian carcinoma and quantitatively appraises the evidence for each gene.

CANCER GENE THERAPY (2023)

Article Oncology

Association of dynamic contrast-enhanced MRI an Fluorodeoxyglucose PET/CT parameters with neoadjuvant therapy response and survival in esophagogastric cancer d 18F-

Samuel J. Withey, Kasia Owczarczyk, Mariusz T. Grzeda, Connie Yip, Harriet Deere, Mike Green, Nick Maisey, Andrew R. Davies, Gary J. Cook, Vicky Goh

Summary: This study found that pre-treatment vascular and metabolic parameters of esophagogastric tumors may be associated with response to neoadjuvant therapy. However, these parameters showed no significant relationship with survival.
Article Oncology

A Novel Radiogenomics Biomarker for Predicting Treatment Response and Pneumotoxicity From Programmed Cell Death Protein or Ligand-1 Inhibition Immunotherapy in NSCLC

Mitchell Chen, Haonan Lu, Susan J. Copley, Yidong Han, Andrew Logan, Patrizia Viola, Alessio Cortellini, David J. Pinato, Danielle Power, Eric O. Aboagye

Summary: This study developed a radiomic-based signature for predicting disease response in patients with NSCLC undergoing PD-1 or PD-L1 immunotherapy. The radiomic signature was validated in two independent testing cohorts and demonstrated good prediction of treatment response and prognosis.

JOURNAL OF THORACIC ONCOLOGY (2023)

Review Radiology, Nuclear Medicine & Medical Imaging

Standalone AI for Breast Cancer Detection at Screening Digital Mammography and Digital Breast Tomosynthesis:A Systematic Review and Meta-Analysis

Jung Hyun Yoon, Fredrik Strand, Pascal A. T. Baltzer, Emily F. Conant, Fiona J. Gilbert, Constance D. Lehman, Elizabeth A. Morris, Lisa A. Mullen, Robert M. Nishikawa, Nisha Sharma, Ilse Vejborg, Linda Moy, Ritse M. Mann

Summary: This study evaluated the performance of artificial intelligence (AI) in the interpretation of digital mammography and digital breast tomosynthesis (DBT). The results showed that standalone AI performed as well as or better than radiologists in digital mammography, but there were insufficient studies to assess its performance in DBT interpretation.

RADIOLOGY (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

[99mTc]-labelled anti-Programmed Death-Ligand 1 single-domain antibody SPECT/CT: a novel imaging biomarker for myocardial PD-L1 expression

Muhummad Sohaib Nazir, Daniel Johnathan Hughes, Gitasha Chand, Kathryn Adamson, Jessica Johnson, Damion Bailey, Victoria Gibson, Hong Hoi Ting, Alexander Lyon, Gary J. R. Cook

Summary: This study determines a non-invasive method for assessing myocardial PD-L1 expression using [Tc-99m]-labelled anti-PD-L1 single-domain antibody (NM-01) SPECT/CT. The study finds that myocardial PD-L1 expression is higher than skeletal muscle in lung cancer patients, and this technique has high reliability and specificity. It can be applied to investigate ICI-associated myocarditis and cardiomyopathies.

EJNMMI RESEARCH (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Inter-rater and intra-rater agreement of [Tc-99m]-labelled NM-01, a single-domain programmed death-ligand 1 (PD-L1) antibody, using quantitative SPECT/CT in non-small cell lung cancer

Daniel Johnathan Hughes, Gitasha Chand, Jessica Johnson, Damion Bailey, Kathryn Adamson, Vicky Goh, Gary J. R. Cook

Summary: This study aims to determine the inter- and intra-rater agreement of the quantitative measurement of [Tc-99m]NM-01 SPECT/CT in NSCLC. The results show that using SUVmax and malignant lesion-to-blood pool ratios can provide accurate assessment of NSCLC. This study validates the effectiveness of [Tc-99m]NM-01 SPECT/CT in NSCLC.

EJNMMI RESEARCH (2023)

Article Oncology

Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study

Sophie Papa, Antonella Adami, Michael Metoudi, Richard Beatson, Molly Sarah George, Daniela Achkova, Evangelia Williams, Sefina Arif, Fiona Reid, Maria Elstad, Nicholas Beckley-Hoelscher, Abdel Douri, Marc Delord, Mike Lyne, Dharshene Shivapatham, Christopher Fisher, Andrew Hope, Sakina Gooljar, Arindam Mitra, Linda Gomm, Cienne Morton, Rhonda Henley-Smith, Selvam Thavaraj, Alice Santambrogio, Cynthia Andoniadou, Sarah Allen, Victoria Gibson, Gary J. R. Cook, Ana C. Parente-Pereira, David M. Davies, Farzin Farzaneh, Anna Schurich, Teresa Guerrero-Urbano, Jean-Pierre Jeannon, James Spicer, John Maher

Summary: This study developed an autologous CD28-based chimeric antigen receptor T-cell (CAR-T) therapy named T4 immunotherapy for locally advanced/recurrent head and neck squamous cell carcinoma (HNSCC). Patient-derived T-cells were engineered to express a panErbB-specific CAR and an IL-4-responsive chimeric cytokine receptor. Intratumoral delivery was used to mitigate off-tumor toxicity. The study demonstrated the safe and effective intratumoral administration of T4 immunotherapy in advanced HNSCC.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2023)

Article Oncology

Radiomics-based decision support tool assists radiologists in small lung nodule classification and improves lung cancer early diagnosis

Benjamin Hunter, Christos Argyros, Marianna Inglese, Kristofer Linton-Reid, Ilaria Pulzato, Andrew G. Nicholson, Samuel V. Kemp, Pallav L. Shah, Philip L. Molyneaux, Cillian Mcnamara, Toby Burn, Emily Guilhem, Marcos Mestas Nunez, Julia Hine, Anika Choraria, Prashanthi Ratnakumar, Susannah Bloch, Simon Jordan, Simon Padley, Carole A. Ridge, Graham Robinson, Hasti Robbie, Joseph Barnett, Mario Silva, Sujal Desai, Richard W. Lee, Eric O. Aboagye, Anand Devaraj

Summary: This study developed a radiomics model to assist in the diagnosis of lung cancer. By extracting radiomics features and using clustering methods, patients were stratified into different risk groups. The model showed high accuracy in predicting malignancy and has potential clinical applications.

BRITISH JOURNAL OF CANCER (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Feasibility of [F-18]fluoropivalate hybrid PET/MRI for imaging lower and higher grade glioma: a prospective first-in-patient pilot study

Shahriar Islam, Marianna Inglese, Matthew Grech-Sollars, Preetha Aravind, Suraiya Dubash, Tara D. Barwick, Kevin O'Neill, James Wang, Azeem Saleem, James O'Callaghan, Giulio Anchini, Matthew Williams, Adam Waldman, Eric O. Aboagye

Summary: MRI and PET are used in neuro-oncology to detect and characterize malignant lesions. In this study, the uptake of FPIA in brain tumors was investigated using PET/MRI.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2023)

Article Radiology, Nuclear Medicine & Medical Imaging

Development and Evaluation of Machine Learning in Whole-Body Magnetic Resonance Imaging for Detecting Metastases in Patients With Lung or Colon Cancer

Andrea G. Rockall, Xingfeng Li, Nicholas Johnson, Ioannis Lavdas, Shalini Santhakumaran, A. Toby Prevost, Shonit Punwani, Vicky Goh, Tara D. Barwick, Nishat Bharwani, Amandeep Sandhu, Harbir Sidhu, Andrew Plumb, James Burn, Aisling Fagan, Georg J. Wengert, Dow-Mu Koh, Krystyna Reczko, Qi Dou, Jane Warwick, Xinxue Liu, Christina Messiou, Nina Tunariu, Peter Boavida, Neil Soneji, Edward W. Johnston, Christian Kelly-Morland, Katja N. De Paepe, Heminder Sokhi, Kathryn Wallitt, Amish Lakhani, James Russell, Miriam Salib, Sarah Vinnicombe, Adam Haq, Eric O. Aboagye, Stuart Taylor, Ben Glocker

Summary: The study aimed to develop a machine learning algorithm to improve radiologists' sensitivity and specificity for metastasis detection in whole-body magnetic resonance imaging (WB-MRI). The results showed that using the algorithm can enhance the detection accuracy and reduce reading times for radiologists.

INVESTIGATIVE RADIOLOGY (2023)

Editorial Material Biochemistry & Molecular Biology

Balancing human and AI roles in clinical imaging

Fiona Gilbert

Summary: Combining artificial intelligence with human expertise can be the best approach to enhance diagnostic accuracy in clinical imaging while ensuring safety.

NATURE MEDICINE (2023)

No Data Available